Clinical Trial Update: Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating methylene blue for refractory vasoplegia in cirrhotics with septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis Liver
• Septic Shock
• Vasoplegia

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Septic Shock, Vasoplegia | Phase 4 | Status: COMPLETED